Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Heath

Showing results (81-90 of 248) with videos related to

Pageof 25
Sort By:
Investigational New Drugs|October 6, 2021
Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumorsElisabeth I Heath, Amy Weise, Ulka Vaishampayan, et al.
Pancreas|May 1, 1995
The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitisD I Heath, A Cruickshank, A M Gudgeon, et al.
Computer Methods in Applied Mechanics and Engineering|August 21, 2023
A stabilized linear finite element method for anisotropic poroelastodynamics with application to cardiac perfusionNamshad Thekkethil, Simone Rossi, Hao Gao, et al.
JCO Oncology Practice|July 11, 2023
Using Music as a Tool for Distress Reduction During Cancer Chemotherapy TreatmentFelicity W K Harper, Allison S Heath, Tanina Foster Moore, et al.
Gut|September 1, 1994
Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosisD I Heath, C Wilson, A M Gudgeon, et al.
JCO Oncology Practice|June 24, 2025
What About the Caregivers? Music Medicine as a Tool for Improving Psychological Well-Being Among Caregivers During Cancer Chemotherapy TreatmentFelicity W K Harper, Tanina Foster Moore, Allison S Heath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC)Shirish M Gadgeel, John C Ruckdeschel, Elisabeth I Heath, et al.
Cancer Metastasis Reviews|November 29, 2018
Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature reviewShijie Sheng, M Margarida Bernardo, Sijana H Dzinic, et al.
American Journal of Translational Research|August 25, 2010
A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancerElisabeth I Heath, Lance K Heilbrun, Jing Li, et al.
Clinical Genitourinary Cancer|April 8, 2016
Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate CancerDipenkumar Modi, Clara Hwang, Hirva Mamdani, et al.
Pageof 25

Showing results (81-90 of 248) with videos related to

Sort By:
Pageof 25
Investigational New Drugs|October 6, 2021
Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumorsElisabeth I Heath, Amy Weise, Ulka Vaishampayan, et al.
Pancreas|May 1, 1995
The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitisD I Heath, A Cruickshank, A M Gudgeon, et al.
Computer Methods in Applied Mechanics and Engineering|August 21, 2023
A stabilized linear finite element method for anisotropic poroelastodynamics with application to cardiac perfusionNamshad Thekkethil, Simone Rossi, Hao Gao, et al.
JCO Oncology Practice|July 11, 2023
Using Music as a Tool for Distress Reduction During Cancer Chemotherapy TreatmentFelicity W K Harper, Allison S Heath, Tanina Foster Moore, et al.
Gut|September 1, 1994
Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosisD I Heath, C Wilson, A M Gudgeon, et al.
JCO Oncology Practice|June 24, 2025
What About the Caregivers? Music Medicine as a Tool for Improving Psychological Well-Being Among Caregivers During Cancer Chemotherapy TreatmentFelicity W K Harper, Tanina Foster Moore, Allison S Heath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC)Shirish M Gadgeel, John C Ruckdeschel, Elisabeth I Heath, et al.
Cancer Metastasis Reviews|November 29, 2018
Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature reviewShijie Sheng, M Margarida Bernardo, Sijana H Dzinic, et al.
American Journal of Translational Research|August 25, 2010
A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancerElisabeth I Heath, Lance K Heilbrun, Jing Li, et al.
Clinical Genitourinary Cancer|April 8, 2016
Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate CancerDipenkumar Modi, Clara Hwang, Hirva Mamdani, et al.
Pageof 25